Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00864682Phase 4Completed
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in pain, sponsored by Benaroya Research Institute. Primary endpoint: Verbal Pain Score. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00864682.